Dasalab 70 Tablet: Your High-Value PCD Pharma Franchise for Oncology

About Dasatinib 70mg: A Targeted Therapy for Chronic Myeloid Leukemia

Tapping into the High-Growth Market for Super-Specialty Drugs

Why Dasalab 70 Tablet is a Profitable Niche Opportunity for Distributors

Partnering for Success with a Quality-Assured Product
Join Our Pharma Franchise for Unmatched Business Support

Home/Products /dasatinib-70-mg-tablet

About the Product

Description


Dasalab 70 Tablet is a critical and advanced pharmaceutical solution in the fight against certain blood cancers. Each tablet contains Dasatinib 70mg, a powerful second-generation tyrosine kinase inhibitor (TKI). This targeted therapy works by specifically blocking the abnormal BCR-ABL protein that drives the uncontrolled proliferation of cancer cells in conditions like Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). Its potent and selective action makes it a cornerstone of treatment, offering a significant advantage over conventional chemotherapy and a viable option for patients who have developed resistance to other therapies.

The oncology market, and specifically the segment for leukemia drugs, is a high-value and high-growth area within the Indian pharmaceutical industry. With the increasing incidence of cancer and a growing emphasis on more effective, targeted therapies, the demand for essential drugs like Dasatinib is both robust and consistent. As a vital component of long-term cancer care regimens, this product ensures high turnover and a stable, recurring revenue stream. This makes the Dasalab franchise a strategic and highly profitable opportunity, allowing you to establish a strong presence in the super-specialty oncology market.

We are dedicated to empowering our franchise partners with all the tools necessary for success in this professional market. Our product is manufactured in a WHO-GMP certified facility, ensuring impeccable quality, efficacy, and safety, which is paramount for a life-saving oncology drug. We provide a complete promotional and marketing kit, including detailed product literature and clinical data, to support your engagement with specialized healthcare professionals. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this lucrative market and establish a reputable and successful business as a key supplier of this critical and top-quality medicine.

Common side effects include hot flashes, headache, fatigue, nausea, joint pain, and dizziness. Serious side effects can include bone thinning (osteoporosis), cardiovascular issues, and liver dysfunction.

Breast cancer treatment (postmenopausal women, hormone receptor-positive) Adjuvant therapy post-surgery or chemotherapy Induction of ovulation in women with infertility (PCOS)

Letomore should only be used under the supervision of a healthcare professional. Inform your doctor about any pre-existing conditions, particularly related to bone health or heart conditions. Seek medical attention immediately if you notice signs of an allergic reaction, such as rash, swelling, or breathing difficulty.

Store Letomore 5 Tablet in a cool, dry place, away from moisture and direct sunlight, at a temperature not exceeding 30°C. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Dasatinib 70mg Tablet in the PCD pharma franchise market?

Dasatinib 70mg Tablet has strong demand in the oncology (targeted anti-cancer therapy) segment, making it a high-value and specialized product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.

Why should medical distributors include Dasatinib Tablets in their product range?

Medical distributors and wholesalers can benefit from consistent demand in chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) treatment under specialist oncology supervision. It strengthens their oncology and specialty medicine portfolio.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for Dasatinib 70mg Tablet?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Dasatinib 70mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this oncology product?

Wholesalers and medical agencies benefit from strong institutional demand, long-term treatment cycles, and steady hospital procurement opportunities when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Dasatinib 70mg Tablet?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this oncology formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.